Literature DB >> 22706738

Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats.

Nermin Karahan1, Mehmet Işler, Ahmet Koyu, Aynur G Karahan, Gülden Başyığıt Kiliç, Ibrahim Metin Cırış, Recep Sütçü, Ibrahim Onaran, Hakan Cam, Muharrem Keskın.   

Abstract

BACKGROUND/AIMS: Intestinal bacteria induce endogenous signals that play a pathogenic role in hepatic insulin resistance and non-alcoholic fatty liver disease. Probiotics could modulate the gut flora and could influence the gut-liver axis. We aimed to investigate the preventive effect of two probiotic mixtures on the methionine choline-deficient diet-induced non-alcoholic steatohepatitis model in rats.
METHODS: Two studies, short-term (2 weeks) and long-term (6 weeks), were carried out using 60 male Wistar rats. The 2-week study included six groups. Rats were fed with methionine choline-deficient diet or pair-fed control diet and were given a placebo or one of two probiotic mixtures (Pro-1 and Pro-2) by orogastric gavage. In the 6-week study, rats were allocated into four groups and were fed with methionine choline-deficient diet or pair-fed control diet and given a placebo or Pro-2. At the end of the 2- and 6-week periods, blood samples were obtained, the animals were sacrificed, and liver tissues were removed. Serum alanine aminotransferase activity was determined; histologic and immunohistochemical analysis was performed for steatosis, inflammation, protein expression of tumor necrosis factor-α, and apoptosis markers.
RESULTS: In both studies, methionine choline-deficient diet caused an elevation of serum alanine aminotransferase activity, which was slightly reduced by Pro-1 and Pro-2. In the 2- and 6-week studies, feeding with methionine choline-deficient diet resulted in steatosis and inflammation, but not fibrosis, in all rats. In the 2-week study, in rats fed with methionine choline-deficient diet and given Pro-1, steatosis and inflammation were present in 2 of 6 rats. In rats fed with methionine choline-deficient diet and given Pro-2, steatosis was detected in 3 of 6 rats, while inflammation was present in 2 of 6 rats. In the 6-week study, in rats fed with methionine choline-deficient diet and given Pro-2, steatosis and inflammation were present in 3 of 6 rat livers. In both the 2- and 6-week studies, methionine choline-deficient diet resulted in tumor necrosis factor-α, proapoptotic Bax, caspase 3, caspase 8, and anti-apoptotic Bcl-2 expression in all rat livers. Pro-1 and Pro-2 treatment influenced protein expression involved in apoptosis and tumor necrosis factor-α in varying degrees.
CONCLUSIONS: Pro-1 and Pro-2 decrease methionine choline-deficient diet-induced steatohepatitis in rats. The preventive effect of probiotics may be due, in part, to modulation of apoptosis and their anti-inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706738     DOI: 10.4318/tjg.2012.0330

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  10 in total

Review 1.  Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.

Authors:  Giulia Paolella; Claudia Mandato; Luca Pierri; Marco Poeta; Martina Di Stasi; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 2.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.

Authors:  Junli Ma; Qihang Zhou; Houkai Li
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

Review 3.  Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Kazuhiro Kotoh; Manabu Nakashima; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

4.  Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences.

Authors:  Roya Kelishadi; Sanam Farajian; Maryam Mirlohi
Journal:  Hepat Mon       Date:  2013-04-09       Impact factor: 0.660

Review 5.  Non-alcoholic fatty liver disease in children: focus on nutritional interventions.

Authors:  Min Yang; Sitang Gong; Shui Qing Ye; Beth Lyman; Lanlan Geng; Peiyu Chen; Ding-You Li
Journal:  Nutrients       Date:  2014-10-28       Impact factor: 5.717

Review 6.  The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease.

Authors:  Sanjoy Roychowdhury; Praveen Conjeevaram Selvakumar; Gail A M Cresci
Journal:  Med Sci (Basel)       Date:  2018-06-05

7.  In Vivo Toxicity and In Vitro Solubility Assessment of Pre-Treated Struvite as A Potential Alternative Phosphorus Source in Animal Feed.

Authors:  Soomin Shim; Seunggun Won; Arif Reza; Seungsoo Kim; Sungil Ahn; Baedong Jung; Byungil Yoon; Changsix Ra
Journal:  Animals (Basel)       Date:  2019-10-11       Impact factor: 2.752

Review 8.  Role of endogenous microbiota, probiotics and their biological products in human health.

Authors:  Gordon S Howarth; Hanru Wang
Journal:  Nutrients       Date:  2013-01-10       Impact factor: 5.717

9.  Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial.

Authors:  Ahmad Shavakhi; Mohammad Minakari; Hassan Firouzian; Raheleh Assali; Azita Hekmatdoost; Gordon Ferns
Journal:  Int J Prev Med       Date:  2013-05

10.  Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis.

Authors:  Anurag S Lavekar; Dhananjay V Raje; Tanuja Manohar; Amarja A Lavekar
Journal:  Euroasian J Hepatogastroenterol       Date:  2017-09-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.